Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: A phantom study

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 9, 2005, Pages 1100-1107

  Verberne, Hein J ^a,c   Feenstra, Christel ^a   De Jong, W Matthijs ^a   Somsen, G Aernout ^b   Van Eck Smit, Berthe L F ^a   Sokole, Ellinor Busemann ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Department of Cardiology ^*  (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Collimator; Iodine 123; Metaiodobenzylguanidine; Quantification; Scatter correction

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ARTICLE; CAMERA; COLLIMATOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ELECTROCARDIOGRAM; HEART; IMAGE QUALITY; LIVER; LUNG; MEDIASTINUM; PHANTOM; PHOTON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RADIATION SCATTERING; THREE DIMENSIONAL IMAGING;

3-IODOBENZYLGUANIDINE; EQUIPMENT FAILURE ANALYSIS; HEART; IMAGE ENHANCEMENT; MEDIASTINUM; MYOCARDIUM; ORGAN SPECIFICITY; PHANTOMS, IMAGING; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SCATTERING, RADIATION; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 25144502393     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1810-3     Document Type: Article

References (20)

1. Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471-7.
2. 123I meta-iodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study. Heart 2001;86:656-60.
3. Patel AD, Iskandrian AE. MIBG imaging. J Nucl Cardiol 2002;9:75-94.
4. 123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure. Heart 1996;76:218-22.
5. Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med 1997;38:1085-9.
6. de Milliano PA, de Groot AC, Tijssen JG, Eck-Smit BL, Van Zwieten PA, Lie KI. Beneficial effects of metoprolol on myocardial sympathetic function: evidence from a randomized, placebo-controlled study in patients with congestive heart failure. Am Heart J 2002;144:E3.
7. Eichhorn EJ, McGhie AL, Bedotto JB, Corbett JR, Malloy CR, Hatfield BA, et al. Effects of bucindolol on neurohormonal activation in congestive heart failure. Am J Cardiol 1991;67:67-73.
8. Gerson MC, Craft LL, McGuire N, Suresh DP, Abraham WT, Wagoner LE. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine. J Nucl Cardiol 2002;9:608-15.
9. Yamazaki J, Muto H, Kabano T, Yamashina S, Nanjo S, Inoue A. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy - clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography. Am Heart J 2001;141:645-52.
10. Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, et al. Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure. J Nucl Med 2002;43:1279-85.
11. Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, et al. Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy. J Am Coll Cardiol 2003;41:574-81.
12. Somsen GA, Verberne HJ, Fleury E, Righetti A. Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies. J Nucl Cardiol 2004;11:126-33.
13. 123I-labelled compounds in clinical practice. Eur J Nucl Med 1999;26:655-8.
14. Inoue Y, Suzuki A, Shirouzu I, Machida T, Yoshizawa Y, Akita F, et al. Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake. J Nucl Cardiol 2003;10:623-32.
15. Ichihara T, Ogawa K, Motomura N, Kubo A, Hashimoto S. Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT. J Nucl Med 1993;34:2216-21.
16. Visser JJ, Sokole EB, Verberne HJ, Habraken JB, van de Stadt HJ, Jaspers JE, et al. A realistic 3-D gated cardiac phantom for quality control of gated myocardial perfusion SPET: the Amsterdam gated (AGATE) cardiac phantom. Eur J Nucl Med Mol Imaging 2004;31:222-8.
17. Yamashina S, Yamazaki J. Role of MIBG myocardial scintigraphy in the assessment of heart failure: the need to establish evidence. Eur J Nucl Med Mol Imaging 2004;31:1353-5.
18. Buvat I, Benali H, Todd-Pokropek A, Di Paola R. Scatter correction in scintigraphy: the state of the art. Eur J Nucl Med 1994;21:675-94.
19. Takeda K, Saito K, Makino K, Saito Y, Aoki S, Koji T, et al. Iodine-123-BMIPP myocardial washout and cardiac work during exercise in normal and ischemic hearts. J Nucl Med 1997;38:559-63.
20. Saito K, Takeda K, Okamoto S, Okamoto R, Makino K, Tameda Y, et al. Detection of doxorubicin cardiotoxicity by using iodine-123 BMIPP early dynamic SPECT: quantitative evaluation of early abnormality of fatty acid metabolism with the Rutland method. J Nucl Cardiol 2000;7:553-61.